anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Evidence

Beat collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 40,452
Current window 25,081-25,110
Pages 1,349
Rows per page 30
Beat: Evidenceclear collectionreset all
18 30 60

Beat

25,081-25,110 of 40,452

filter-aware
18
The slide compares cytokine inhibition across three cohorts (MAD3 Healthy Subjects, Part C AD Patients, Part C HS Patients) using two different stimuli (LPS and R848).Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · Desire1 hit
19
The chart specifically visualizes IL-6 reduction over time, while the table summarizes max reduction across four markers.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · Desire1 hit
20
The slide displays 12 individual bar charts (4 for AD, 8 for HS) representing gene expression changes.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · Desire1 hit
21
Data based on N=7 patients. Includes error bars representing standard error or confidence intervals.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · DesireLoop · Aha Moment1 hit
22
The chart tracks patient outcomes over time, showing a shift from severe/moderate to mild categories.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · DesireLoop · Aha Moment1 hit
23
Includes before/after photography, clinical efficacy table, and biomarker reduction charts.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · DesireLoop · Aha Moment1 hit
24
The slide uses a comparison table to highlight efficacy metrics (EASI, Pruritus NRS) across different time points and benchmarks.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · DesireLoop · Aha Moment1 hit
25
Data presented for All HS Patients (N=12) and Moderate to Severe (N=10) subgroups.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · Desire1 hit
26
Data presented across three line charts comparing 'All HS Patients' vs 'Moderate to Severe' subgroups.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · Desire1 hit
27
The charts demonstrate a shift from higher severity scores (orange/red) to lower severity scores (blue/black) over time.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · Desire1 hit
28
Includes patient profile, clinical efficacy table, before/after photos, and a bar chart of biomarker reduction.Kymera | Investor Presentation Deck | 60 slides · Kymera
Pitch deck Investor relations Beat · Desire1 hit
07
Uses a process-flow style diagram to map specific market segments to macro-level value drivers.Limbach Holdings | Investor Presentation Deck | 26 slides · Limbach
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
09
The slide uses a comparison framework to contrast two revenue streams.Limbach Holdings | Investor Presentation Deck | 26 slides · Limbach
Pitch deck Investor relations Beat · Solution1 hit
17
Includes footnotes regarding financial projections and conference schedule.Limbach Holdings | Investor Presentation Deck | 26 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
18
Limbach Holdings | Investor Presentation Deck | 26 slidesLimbach Holdings | Investor Presentation Deck | 26 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
10
The slide uses a process-flow visual to link specific market segments to broader economic themes like 'Mission-Critical', 'Durable Demand', and 'Economic Resilience'.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Market SizeLoop · Cost Of Inaction1 hit
12
The slide uses a maturity model framework (Limbach 1.0 to 3.0) to illustrate business model evolution.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Business Model1 hit
13
The chart uses a dual-axis approach to correlate margin expansion with ODR revenue mix shift.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Business Model1 hit
14
Uses a funnel-like diagram leading into a Venn-style hub-and-spoke model.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Business Model1 hit
15
The slide outlines two distinct M&A strategies: tuck-ins for existing markets and new geography expansion.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Business Model1 hit
16
Mentions '80/20 mindset' which refers to the Pareto Principle.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Business Model1 hit
18
Includes standard financial disclaimer footnotes.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
19
Limbach Holdings | Investor Presentation Deck | 27 slidesLimbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
20
Limbach Holdings | Investor Presentation Deck | 27 slidesLimbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
21
The slide uses stacked bar charts to break down performance by GCR and ODR segments.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
22
The slide uses stacked bar charts to show segment contributions (GCR vs ODR) and simple bar charts for EBITDA.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
23
Includes footnotes explaining the calculation of net debt and references to SEC filings.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
24
Includes detailed footnotes regarding the use of non-GAAP measures and specific restructuring costs.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
25
Includes detailed line-item adjustments such as stock-based compensation, debt modification losses, and transition costs.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit
26
Includes footnotes regarding EBITDA reconciliation and FCF definition.Limbach Holdings | Investor Presentation Deck | 27 slides · Limbach
Pitch deck Investor relations Beat · Financials1 hit